Review on diabetes mellitus

  • P.Vyshnavi B.Pharmacy final year student, Jagan’s Institute of Pharmaceutical Sciences, Nellore
  • P.Narayana swamy Associate Professor, Dept.of Pharmacy Practice, Jagan’s Institute of Pharmaceutical Science, Nellore
  • P.Venkatesh Principal Jagan’s Institute of Pharmaceutical Science, Nellore

Abstract

Diabetes is one of the most common chronic disease, which occurs when the pancreas does not produce enough insulin, or when the body cannot effectively use the insulin it produces. This leads to an increased concentration of glucose in the blood (hyperglycemia) Diabetes mellitus (DM) also known as simply diabetes, is a group of metabolic diseases in which there are high blood sugar levels over a prolonged period This high blood sugar produces the symptoms of frequent urination, increased thirst, and increased hunger. Untreated, diabetes can cause many complications. Acute complications include diabetic ketoacidosis and non-kenotic hyperosmolar coma. Serious long-term complications include heart disease, stroke, kidney failure, foot ulcers and damage to the eyes. Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced Type 1 diabetes is a chronic autoimmune disease characterized by insulin deficiency and resultant hyperglycemia. Knowledge of type 1 diabetes has rapidly increased resulting in a broad understanding about many aspects of the disease, including its genetics, epidemiology, immune and β-cell phenotypes, and diseased burden. Interventions to preserve β cells have been tested, type 1 diabetes and our ability to standardize clinical care and decrease disease-associated complications and burden. The presence of additional chronic conditions has a significant impact on the treatment and management of type 2 diabetes (T2DM). Little is known about the patterns of comorbidities in this population. The aims of this study are to quantify comorbidity.

Keywords: Diabetes mellitus, autoimmune disease, β cells

Downloads

Download data is not yet available.

References

1. Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, Connolly V, King H. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care, 2005; 28: 2130–2135.
2. Köster I, Huppertz E, Hauner H, Schubert I. Direct costs of diabetes mellitus in Germany - CoDiM 2000–2007.
3. Kaiser A, Vollenweider P, Waeber G, Marques-Vidal P. Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: the study. Diabetic Med., 2012; 29: 190–197.
4. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK: Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before theonset of clinical diabetes?. JAMA, 1990;
5. World Health Organization. DiabetesFactsheet. Geneva: World Health Organization; 2013.
6. Gullies CL, Lambert PC, Abrams KR, et al. Differenstrategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ. 2008; 336(7654): 1180–1185.
7. Currie CJ, Gale EA, Poole CD. Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007*. Diabetic Med., 2010; 27(8): 938–9
8. Massi-Benedetti M. The cost of diabetes Type II IN Europe: the CODE-2 Study. Diabetologia, 2002; 45(7): S1–S4.
9. Libel A, Neiss A, Spannheimer A, et al. Complications, co-morbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany—results from the CODE-2 study. Explain Endocrinol Diabetes, 2002; 110(1): 10–16.
10. Bottomley JM, T2ARDIS Steering Committee Managing care of type 2 diabetes. Learnings from ARDIS. Br J Diabetes Vasc Dis., 2001; 1: 68–72.
Published
26/01/2022
Statistics
601 Views | 456 Downloads
Citatons
How to Cite
P, V., P, N. swamy, & P, V. (2022). Review on diabetes mellitus. Journal of Innovations in Applied Pharmaceutical Science (JIAPS), 7(1), 24-27. https://doi.org/10.37022/jiaps.v7i1.273
Section
Review Article(S)